Tumor cell-derived IL-23 promotes hepatocellular carcinoma progression via an autocrine IL-23/EGFR/AKT signaling axis. Zhou X, Chen Y, Li J, Zhang Y, et al. Biochem Biophys Res Commun 2026;822:153893.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou X, Chen Y, Li J, Zhang Y, et al. Tumor cell-derived IL-23 promotes hepatocellular carcinoma progression via an autocrine IL-23/EGFR/AKT signaling axis. Biochem Biophys Res Commun 2026;822:153893.
PMID: 42127515